THU331 Glycemic Variability In Critically Ill Sepsis Patients Comorbid With COVID-19: Relative Impact Of Diabetes And/Or Obesity

Disclosure: J. Rebernigg: None. K. Baez: None. N. Torres Rivera: None. B. Contreras: None. S. Yenari: None. K. Hamad: None. W. Wiese-Rometsch: None. V. Farhangi: None. •While certain endocrinopathies are known to increase dysglycemia in critically ill patients with sepsis or COVID-19, the impact on...

Descripción completa

Detalles Bibliográficos
Autores principales: June Rebernigg, Janevi, Baez, Karla, Torres Rivera, Nicole, Contreras, Berkis, Yenari, Sage, Hamad, Karen, Wiese-Rometsch, Wilhelmine, Farhangi, Vida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553389/
http://dx.doi.org/10.1210/jendso/bvad114.765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553389/
http://dx.doi.org/10.1210/jendso/bvad114.765

Ejemplares similares